Bayer AG

Bayer AG maintains a capital structure characterized by significant leverage, with total liabilities of €78.6 billion against total equity of €25.9 billion, resulting in a debt-to-equity ratio of 1.44. The company holds €6.7 billion in cash and equivalents, which is insufficient to cover its €37.4 billion in long-term debt, leading to a negative net cash position. Liquidity is assessed as medium risk, supported by a current ratio of 1.01, indicating that current assets barely exceed current liabilities. The market capitalization stands at €49.2 billion, trading at a price-to-book ratio of 1.9.

Profitability metrics are currently negative, reflecting operational challenges. The company reported an operating income of -€1.1 billion and a net income of -€3.6 billion on revenues of €45.6 billion. This results in a return on equity of -8.31% and a return on assets of -2.06%. The enterprise value to EBITDA ratio is exceptionally high at 630.0, driven by depressed earnings, while the EV-to-revenue ratio is 1.77. These figures indicate that the company is currently destroying shareholder value on an accounting basis, with gross profit of €26.8 billion failing to cover operating expenses and interest costs.

Bayer AG (BAYN.DE) exhibits no material changes in its fundamental profile compared to prior analysis, with the system confirming stability across 17 reviewed fields. This lack of significant deviation suggests a period of operational and strategic continuity for the German pharmaceutical and life sciences company, as no new events or shifts in key metrics were detected during the assessment window. The company’s structural footprint remains consistent, characterized by membership in two major indices and a concentrated top holder base comprising a single entity. With one officer recorded in the current dataset, the leadership structure appears static, reinforcing the narrative of an established corporate governance framework without recent executive turnover or expansion. Market attention, as measured by cross-source signal dispatches, has been sporadic over the recent 30-day period. While the majority of days from late June through mid-July 2026 saw zero dispatches, minor activity occurred on July 1 (1 dispatch), July 2 (5 dispatches), July 4 (1 dispatch), and July 9 (1 dispatch). However, the absence of sentiment data for these instances prevents any definitive conclusion regarding the tone or impact of this limited coverage. Ultimately, the synthesis of available data points to a quiet phase for Bayer AG, with no analyst estimates, ESG updates, or financial revisions driving immediate market reaction. Investors should note that the current landscape is defined by the absence of new material developments, implying that existing valuations and strategic outlooks remain the primary reference points until further data emerges.

Analysts project 16.5% upside to a mean price target of EUR 53.69, reflecting a consensus buy recommendation.

Long-term debt decreased to EUR 37.4 billion in FY2026, indicating a reduction in leverage compared to prior years.

Revenue CAGR of 0.8% over four years suggests modest stability despite recent annual declines in top-line growth.

The company faces high credit risk and medium liquidity risk, signaling significant financial stability concerns.

Revenue €13.40B, −2,4% YoY; Operating income +51,8% YoY.

• ▍Revenue €13.40B, −2,4% YoY
• ▍Operating income +51,8% YoY
• ▍Net income +112,7% YoY
• ▍Free cash flow +72,7% YoY
• ▍Net margin 20.6%

Revenue €11.44B, −2,5% YoY; Operating income −2 242,5% YoY.

• ▍Revenue €11.44B, −2,5% YoY
• ▍Operating income −2 242,5% YoY
• ▍Net income −1 021,5% YoY
• ▍Free cash flow −542,4% YoY
• ▍Net margin -32.8%

Revenue €9.66B, −3,1% YoY; Operating income +85,8% YoY.

• ▍Revenue €9.66B, −3,1% YoY
• ▍Operating income +85,8% YoY
• ▍Net income +77,0% YoY
• ▍Free cash flow +79,4% YoY
• ▍Net margin -10.0%

Revenue €10.74B, −3,6% YoY; Operating income −97,5% YoY.

• ▍Revenue €10.74B, −3,6% YoY
• ▍Operating income −97,5% YoY
• ▍Net income −485,3% YoY
• ▍Free cash flow −165,4% YoY
• ▍Net margin -1.9%

Revenue €13.74B; Operating income €2.32B.

• ▍Revenue €13.74B
• ▍Operating income €2.32B
• ▍Net margin 9.5%

Revenue €11.73B; Operating income €134.0M.

• ▍Revenue €11.73B
• ▍Operating income €134.0M
• ▍Net margin -2.9%

Revenue €9.97B; Operating income -€3.82B.

• ▍Revenue €9.97B
• ▍Operating income -€3.82B
• ▍Net margin -42.0%

Revenue €11.14B; Operating income €525.0M.

• ▍Revenue €11.14B
• ▍Operating income €525.0M
• ▍Net margin -0.3%

Revenue €45.58B, −2,2% YoY; Operating income −1 416,9% YoY.

• ▍Revenue €45.58B, −2,2% YoY
• ▍Operating income −1 416,9% YoY
• ▍Net income −41,9% YoY
• ▍Free cash flow −53,3% YoY
• ▍Net margin -7.9%

Revenue €46.61B, −2,2% YoY; Operating income −111,6% YoY.

• ▍Revenue €46.61B, −2,2% YoY
• ▍Operating income −111,6% YoY
• ▍Net income +13,2% YoY
• ▍Free cash flow +66,0% YoY
• ▍Net margin -5.5%

Revenue €47.64B, −6,1% YoY; Operating income −91,3% YoY.

• ▍Revenue €47.64B, −6,1% YoY
• ▍Operating income −91,3% YoY
• ▍Net income −170,9% YoY
• ▍Free cash flow −214,9% YoY
• ▍Net margin -6.2%

Revenue €50.74B, +15,1% YoY; Operating income +109,1% YoY.

• ▍Revenue €50.74B, +15,1% YoY
• ▍Operating income +109,1% YoY
• ▍Net income +315,0% YoY
• ▍Free cash flow +735,5% YoY
• ▍Net margin 8.2%